Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 14 July 2009, doi:10.1136/bmj.b2481
Cite this as: BMJ 2009;339:b2481
Early results of laparoscopic fundoplication show promise, but confirmation is needed
| The first 150 words of the full text of this article appear below. |
Symptoms of gastro-oesophageal reflux are common—about 25% of the community experience heartburn and 5% have symptoms daily.1 Proton pump inhibitors are the mainstay of treatment for moderate to severe symptoms because randomised controlled trials (RCTs) show they are the most effective medical treatment.2 When these drugs are discontinued symptoms often relapse, so most patients take them long term.3 This is inconvenient for patients and expensive for the health service. Concerns also exist over the long term safety of this treatment—continued acid suppression is associated with increased risk of infective diarrhoea and hip fracture,4 5 although whether these associations are causal is unclear.
The alternative to long term treatment with proton pump inhibitors is surgery. In the linked study (doi:10.1136/bmj.b2576),6 Epstein and colleagues report the results of a cost effectiveness analysis of a large RCT by Grant and colleagues comparing laparoscopic fundoplication with proton pump inhibitors.7 The advent of this
Alexander C Ford, lecturer in medicine1, Paul Moayyedi, professor of gastroenterology2
1 Department of Academic Medicine, St Jamess University Hospital, Leeds LS9 7TF, 2 Gastroenterology Division, McMaster University, Health Sciences Centre, Hamilton, ON, Canada L8N 3Z5
alexf12399@yahoo.com
Read all Rapid Responses